D&C biotechnology Inc.

D&C Biotechnology Secures ₩1 Billion Pre-Series A Funding

  • 2023.07.03

D&C Biotechnology Co., Ltd. (CEO Park Sung-soo), a developer of next-generation urine diagnostic solutions, announced on the 3rd that it has successfully raised ₩1 billion in its Pre-Series A funding round.

 

This funding round saw new participation from U.S.-based investors Quantum F&A LLC and KFFI, as well as Hallym University Technology Holdings. Existing investor Mirae Science and Technology Holdings also contributed as a follow-up investor.

 

In February, D&C Biotechnology received seed funding from Low Partners, Mirae Science and Technology Holdings, and History Venture Investment. With this new round secured just four months later, the company has demonstrated its technological innovation, business potential, and growth prospects.

 

Founded in September 2021, D&C Biotechnology is a startup specializing in the development of biosensor-based in-vitro diagnostic solutions. The company has addressed fundamental issues such as the waste of medical personnel, contamination, and infection caused by traditional urine testing methods. Its proprietary technology enables “One-Step” testing with immediate analysis and result transmission following sample collection, through its advanced urinalysis precision analyzer and test kits.

 

CEO Park Sung-soo expressed his ambitions, stating, “With this overseas investment, we aim to strengthen our global capabilities and accelerate the commercialization of our solutions to meet the expectations of medical institutions worldwide.”

© 2025 D&C Biotechnology Inc. All Rights Reserved.

위로 스크롤
Close

Data Privacy Notice (Privacy Policy)

Article 1 (Consent to Collection of Personal Information) D&C Biotechnology has set up a procedure whereby users can click the “Agree” or “Cancel” button for the content of D&C Biotechnology’s Privacy Policy or Terms of Use. By clicking the “Agree” button, you are deemed to have consented to the collection of personal information.

 

Article 2 (Personal Information Collection Items) The personal information items processed for consultation through online inquiries are as follows. Collection items: Name, Email, Phone number

 

Article 3 (Purpose of Use of Personal Information) D&C Biotechnology does not disclose users’ personal information without prior consent and collects personal information for smooth customer consultation and provision of various services as follows. All information will not be used for purposes other than those stated above, and prior consent will be obtained if the scope of information collected, purpose of use, or usage changes. Company name, name: Confirmation of identity for product consultation Email, Phone number: Delivery of product consultation and event-related notifications, provision of new service and new product information (DM, SMS, email, etc.) Users can refuse consent to the collection/use of personal information. However, if you refuse consent, online consultation is not possible and you may be restricted in using the service and receiving benefits.

 

Article 4 (Retention and Use Period of Personal Information) In principle, after the purpose of collecting and using personal information is achieved, the information is destroyed without delay. However, if there is a need for preservation in accordance with the provisions of related laws such as the Commercial Law, the Consumer Protection Act in E-commerce, etc., the company keeps the information for a certain period specified in related laws. In this case, the company uses the information stored only for the purpose of its preservation, and the preservation period is as follows. Record of contract or subscription withdrawal: 5 years (Consumer Protection Act in E-commerce, etc.) Record of consumer complaints or dispute resolution: 3 years (Consumer Protection Act in E-commerce, etc.) Record of collection/processing and use of credit information: 3 years (Act on the Use and Protection of Credit Information)

 

The company securely processes valuable user personal information and destroys personal information in the following ways to prevent leaks. Personal information printed on paper is destroyed by shredding or incineration. Personal information stored in electronic file format is deleted using a technical method that cannot reproduce the record

Close

Unauthorised Email Collection is Prohibited

[Unauthorised Email Collection is Prohibited]

 

The unauthorized collection of email addresses posted on this website, through email collection programs or any other technical devices, is strictly prohibited. This includes collecting email addresses without the prior consent of the website operator or administrator. Such unauthorized collection of email addresses is illegal. Violators will be subject to criminal punishment under

 

Article 50-2 of the Act on Promotion of Information and Communications Network Utilization and Information Protection.

 

Article 50-2 of the Act on Promotion of Information and Communications Network Utilization and Information Protection (Prohibition of Unauthorized Collection of E-mail Addresses)

 

  1. No one shall use a program or any other technical device to automatically collect email addresses from the internet website, without the prior consent of the website operator or administrator.
  2. No one shall sell or distribute email addresses collected in violation of paragraph 1.
  3. No one shall knowingly use email addresses, collected, sold or distributed in violation of paragraphs 1 and 2, for the purpose of transmitting information.